Montefiore Einstein Joins Dandelion Health Consortium to Advance AI-Driven Clinical Research

Montefiore Einstein has entered a strategic partnership with Dandelion Health, Inc. to strengthen its capabilities in clinical care and drug development, announced in a press release. Montefiore Einstein joins the Dandelion Consortium, which includes hospital networks such as Sharp HealthCare, Texas Health Resources, and Sanford Health.

The collaboration gives Montefiore Einstein access to Dandelion's platform, which securely and ethically provides anonymized patient data, including medical images, waveform data, clinical notes, and structured records. This data supports life sciences companies and AI developers in creating, validating, and implementing healthcare solutions.

Montefiore Einstein will use the platform to study disease mechanisms and reduce barriers in early-stage clinical research. Insights derived from anonymized clinical notes, social determinants of health, and medical imaging will help develop models to improve patient care and clinical practices.

Dandelion’s system supports the full cycle of AI product development and ensures all data is managed to strict privacy and security standards. Montefiore Einstein’s participation expands the consortium’s national database, enhancing research diversity across healthcare environments.